sotorasib,adagrasib
amgen,mirati 
['lumakras', 'adagrasib', 'mirati']
mirati therapeutics is pulling out all the stops to beef up its case for adagrasib, as the biotech could be 18 months behind amgen s lumakras to market if approved by the fda in december. #asco22 
The biopharma world is here. Get the industry’s most comprehensive daily news report at https://t.co/rXFyNyZcJs